Familial clustering of end-stage renal disease in blacks with lupus nephritis

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
B I FreedmanG M Kammer

Abstract

The factors that determine a patient's susceptibility to specific target organ involvement in systemic lupus erythematosus (SLE) remain unknown. Lupus nephritis can be a particularly devastating complication, with an increased mortality and the risk of progressive renal damage resulting in end-stage renal disease (ESRD). This analysis was performed to determine whether renal disease aggregated in select families or was a sporadic complication in patients with SLE. We compared the family history of ESRD in 50 patients with SLE complicated by lupus nephritis with 37 controls who had SLE but lacked nephritis after a mean follow-up duration of more than 11 years. The frequency of relatives with ESRD in the lupus nephritis cases was compared with that in controls using Fisher's exact test (significance at P < or = 0.05). Fifty percent (25) of the 50 lupus nephritis patients were black and 50% (25) white, in contrast to 35% (13) and 65% (24) of the 37 lupus non-nephropathy controls, respectively. A first-, second-, or third-degree relative with ESRD was present in 16% (eight) of the 50 lupus nephritis cases and in 0% of the 37 SLE non-nephropathy controls (P = 0.019, Fisher's exact test, two-tail). Twenty-eight percent (seven) of the...Continue Reading

Citations

Apr 11, 2000·Current Opinion in Nephrology and Hypertension·V D NenovB M Brenner
Oct 4, 2000·International Reviews of Immunology·F C Arnett
Jul 4, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mark LambieSteve Smith
Oct 16, 2010·Lupus·M Y Mok, W L Li
Nov 11, 2015·Nature Reviews. Nephrology·Barry I Freedman, Arthur H Cohen
Dec 6, 2017·Annals of Internal Medicine·Sneh LataAli G Gharavi
Nov 21, 2017·Nephrology·Philip Kam-Tao LiUNKNOWN Hong Kong Society of Nephrology
Jan 12, 1999·Lupus·B P Tsao
Mar 20, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Meredith A Bostrom, Barry I Freedman
Dec 18, 2009·Clinical Transplantation·A Reeves-DanielK R Daniel
Jun 7, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Barry I Freedman, Karl Skorecki
Jan 12, 1999·Lupus·M A Dooley, R J Falk
Sep 24, 1999·Current Opinion in Nephrology and Hypertension·J R SchellingJ R Sedor
Oct 27, 2001·Seminars in Dialysis·S G Satko, B I Freedman
Apr 10, 2004·Current Opinion in Nephrology and Hypertension·Scott G Satko, Barry I Freedman
Mar 25, 2006·American Journal of Nephrology·Alexander S Goldfarb-RumyantzevLisa Cannon-Albright
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Elizabeth S OmmenBarbara Murphy
Jun 14, 2014·Journal of the American Society of Nephrology : JASN·Sharon A ChungUNKNOWN International Consortium for Systemic Lupus Erythematosus Genetics
Jun 9, 2007·Seminars in Dialysis·Scott G SatkoBarry I Freedman
Nov 14, 2017·Nephron·Delshad Saleh AkrawiBengt Zöller
Jul 23, 1999·Renal Failure·P W Mueller
Feb 8, 2014·Arthritis & Rheumatology·Barry I FreedmanUNKNOWN Lupus Nephritis–End‐Stage Renal Disease Consortium
Oct 23, 2018·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Barry I FreedmanJeffrey B Kopp
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Sylvia Paz B RamirezStephen I-Hong Hsu
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Barry I Freedman
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Sudha K IyengarJohn R Sedor
Jan 24, 2002·Journal of the American Society of Nephrology : JASN·Francesco Paolo SchenaCarlo Manno
Nov 25, 2003·Kidney International·Robert B Toto
Feb 28, 2002·The American Journal of the Medical Sciences·Janice P Lea
Mar 9, 2005·Kidney International. Supplement·Scott G SatkoShahriar Moossavi
Aug 20, 2005·Kidney International. Supplement·Sanjay K Agarwal
Jun 29, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Claudine JurkovitzWilliam M McClellan
Mar 10, 2005·The Medical Clinics of North America·Scott G Satko, Barry I Freedman
Feb 19, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H YuB I Freedman
Aug 4, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B I FreedmanS Pegram

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
B I FreedmanB J Spray
Journal of the American Society of Nephrology : JASN
B J SprayB I Freedman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
B I FreedmanV M Buckalew
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
T BakirS Erkul
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
D F O'DeaP S Parfrey
© 2021 Meta ULC. All rights reserved